缓激肽
医学
腺苷
再灌注损伤
缺血
药理学
机制(生物学)
去甲肾上腺素
内科学
多巴胺
受体
认识论
哲学
作者
Kuldeep Kumar,Pooja Rawat,Simrat Kaur,Nirmal Singh,Harlokesh Narayan Yadav,Dhandeep Singh,Amteshwar Singh Jaggi,Dimple Sethi
出处
期刊:Current drug research reviews
[Bentham Science]
日期:2023-07-18
卷期号:16 (3): 268-288
标识
DOI:10.2174/2589977515666230717120828
摘要
Myocardial ischemic injury is a primary cause of death among various cardiovascular disorders. The condition occurs due to interrupted blood supply and vital nutrients (necessary for normal cellular activities and viability) to the myocardium, eventually leading to damage. Restoration of blood supply to ischemic tissue is noted to cause even more lethal reperfusion injury. Various strategies, including some conditioning techniques like preconditioning & postconditioning have been developed to check detrimental effects of reperfusion injury. Many endogenous substances have been proposed to act as initiator, mediators and end effectors of these conditioning techniques. Substances like adenosine, bradykinin, acetylcholine, angiotensin, norepinephrine, opioids, etc., have been reported to mediate cardioprotective activity. Among these agents, adenosine has been widely studied and suggested to have the most pronounced cardioprotective effects. The current review article highlights the role of adenosine signaling in the cardioprotective mechanism of conditioning techniques. The article also provides an insight into various clinical studies that substantiate the applicability of adenosine as a cardioprotective agent in myocardial-reperfusion injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI